Navigation Links
Novel Technique Can Enhance Stem Cell Multiplication By 30 Fold

A novel method which can aid in the multiplication of adult stem cells, yielding a 30 fold enhanced harvest has been discovered.// This finding could eventually pave way for the development of refinement in bone transplantation and gene therapy techniques.

The use of adult stem cells is encouraged to a great extent as it is associated with less ethical concerns and surpasses the utilization of human embryos, generated for reproductive purposes. However, a number of scientific challenges have to be overcome before these cells can be maximally exploited.

Technical aspects related to the isolation and in-vivo culture of adult stem cells is still in its infancy. Signals that induce the differentiation of adult stem cells into are poorly understood. The limited availability of adult stem cells in human tissues is also a major limiting factor.

The researchers of the present study were determined to develop an effective mechanism to accelerate the multiplication process following isolation from tissue. Hematopoietic stem cells (derived from fetal tissue of mice), capable of giving rise to blood cell components and cells of the immune system were taken up for the study.

The researchers were able to identify a specialized group of cells (different from stem cells) from the isolate. The stem cells were found to be dependent on the newly discovered cells for their growth and multiplication. The stem cells died when they were placed in an environment devoid of these cells. Based on this striking observation, the researchers began to look for specific gene expressions that were active in the new cell population.

It was hypothesized that such genes could code for growth factors or other similar substances, critical for stem cell growth and multiplication. The researchers employed microarray technique to locate such genes. One such identified component was Insulin like growth factor (IGF-2). A 8-fold increase in the stem cell population was observed when the hematopoietic cells were mixed with purified IGF-2.

Abundant expression of two other factors called Angiopoietin-like 2 (angpt12) and Angiopoietin-like –3 (angpt13) were also found. When these components were mixed with IGF-2, a 30-fold increase in the stem cell multiplication could be seen.

Stem cell therapy in the form of bone marrow transplantation remains a viable, life-saving option for patients with hematological malignancies. The stem cells can either be obtained from the bone marrow or even cord blood, though the latter is most commonly used. If this finding can be applied to the isolate, then perhaps, we could have adequate stem cells to treat a particular patient.

Gene therapy is yet another area, where the above finding can be useful. Issues related to the possibility of carcinogenesis as a consequence of gene therapy has to a large extent restricted the approval of any gene-therapy clinical trials.

The study has led to an improved understanding of the stem cell biology, stem cell therapy and research. The researchers are further interested in knowing whether similar results can be obtained for human cord blood as well.
'"/>




Related medicine news :

1. Novel "CYCLOSPORINE CAPSULE FORMULATION" to be launched
2. Novel biopsy technique for prostate cancer
3. Novel computer model for breast cancer
4. Novel research on liver cancer
5. Novel way to fight cancer
6. Novel test for bowel cancer
7. Novel Anti-Neutrophilic Effect produced by Salmeterol in mild asthma patients
8. Novel Therapy for Chronic Problem
9. Blood Sugar Kept In Control By Novel Protein
10. Novel antibiotic dressing developed for improved wound healing
11. United Kingdom Is Lagging In Novelty In The Field Of Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/2/2016)... ... December 02, 2016 , ... On Dec. 2, 2016, CURE® magazine will ... Diego honoring the 2016 MPN Heroes—eight individuals who have made a difference in the ... beyond the standard of care, demonstrating leadership within the MPN community and/or a commitment ...
(Date:12/2/2016)... ... December 02, 2016 , ... More than 100 business, civic, ... to attend the UNCF Dothan-Wiregrass Mayor’s Luncheon Dec. 9, 2016. This inaugural event, ... and operating support to UNCF-member institutions, including Miles College, Oakwood University, Tuskegee University, ...
(Date:12/2/2016)... ... December 02, 2016 , ... ... launch of its 60-day free trial program for all of the company’s desktop ... offer a truly hassle free experience. , FlexiSpot’s unique desktop risers use an ...
(Date:12/2/2016)... ... 2016 , ... The annual time frame to change Medicare health and prescription ... December 7th. Currently-enrolled Medicare beneficiaries who are looking to switch from their current plan ... to make changes during this period order for their new policy to go into ...
(Date:12/2/2016)... ... December 02, 2016 , ... With the number of pain ... an injury, patients must find the one that works for them. When an inventor ... a machine that worked and decided to share it with others. , He developed ...
Breaking Medicine News(10 mins):
(Date:12/2/2016)... NEW YORK , December 2, 2016 ... at 5,251.11, down 1.36%; the Dow Jones Industrial Average edged ... closed at 2,191.08, down 0.35%. Losses were broad based as ... Today, Stock-Callers.com has initiated research reports on the following Services ... N.V. (NASDAQ: QGEN ), INC Research Holdings Inc. ...
(Date:12/2/2016)... Conn. , Dec. 1, 2016  Today, Simpson ... announced the honor of being selected as winners of ... Simpson Healthcare Executives Website at the PLATINUM level, Blue ... Training Module at the GOLD Level, and our proprietary ... At Simpson Healthcare Executives, we are excited to ...
(Date:12/2/2016)... -- bioLytical Laboratories (das "Unternehmen"), ein Weltführer bei schnellen Tests ...  in einer Version mit geringeren Kosten einzuführen.  ... ... New: INSTI Self Test! (PRNewsFoto/bioLytical Laboratories) ...      (Photo: http://photos.prnewswire.com/prnh/20161201/444833 ) Der ...
Breaking Medicine Technology: